Taiwanese Pharmaceuticals & Biotech Top Dividend Payers

Syngen BiotechLtd

Market Cap: NT$3.0b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

Standard Chemical & Pharmaceutical

Market Cap: NT$11.3b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

Bora Pharmaceuticals

Market Cap: NT$58.7b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.8b

Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.

TTY Biopharm

Market Cap: NT$20.5b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

TSH Biopharm

Market Cap: NT$2.0b

Develops and markets pharmaceutical products in Taiwan.

YungShin Global Holding

Market Cap: NT$14.2b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

Sunmax Biotechnology

Market Cap: NT$21.5b

A biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.9b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Formosa Laboratories

Market Cap: NT$6.3b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.2b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

Nang Kuang Pharmaceutical

Market Cap: NT$3.7b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.